ISSN: 1080-6059

Print this page  | Close Window

Ceftriaxone-Resistant Salmonella enterica Serotype Newport, France

Svetlana Egorova,*1 Mohammed Timinouni,*2 Marie Demartin,* Sophie A. Granier,† Jean M. Whichard,‡ Vartul Sangal,§ Laëtitia Fabre,* Aurélia Delauné,* Maria Pardos,* Yves Millemann,¶ Emmanuelle Espié,# Mark Achtman,§** Patrick A.D. Grimont,* and François-Xavier Weill*
*Institut Pasteur, Paris, France; †Agence Française de Sécurité Sanitaire des Aliments, Maisons-Alfort, France; ‡Centers for Disease Control and Prevention, Atlanta, Georgia, USA; §Max-Planck-Institute für Infektionsbiologie, Berlin, Germany; ¶Ecole Nationale Vétérinaire d’Alfort, Maisons-Alfort; #Institut de Veille Sanitaire, Saint-Maurice, France; and **University College, Cork, Ireland
Vol. 14, No. 6 • June 2008


Appendix Table. Characteristics of Samonella spp. isolates used in this study*

Isolate Date of isolation Area of isolation† Patient age group‡, sex Source Antimicrobial drug resistance phenotype§ Class 1 integron size, kb
(gene cassette)
PFGE profile¶ MLST type Plasmid profile# Plasmid restriction profile**

S. Newport isolates

00-3525 2000 Jun 75 III-F Stool AFoxCazSSuCTe _ New6b (JJPX01.0014) ST45 100, 50, 3.5 R4
00-3767 2000 Jun 60 III-F Stool AFoxCazSSuCTe _ New2 ST45 >125, 3.5 R3
00-3784 2000 Jun 75 II-M Stool AFoxCazSSpKToGSuCTe 1 (aadA24) New3 ST45 >125, 7 R1
00-4165 2000 Jul 62 II-M Stool AFoxCazSSpKToGSuCTe 1 (aadA24) New 3 ST45 >125, 7 R5
00-4652 2000 Jul 60 II-F Stool AFoxCazSSuCTe _ New 4 ND >125, 3.5 R4
00-5089 2000 Jul 2A II-F Stool AFoxCazSSpKToGSuCTe 1 (aadA24) New 3 ST45 >125, 7 R1
00-6399 2000 Sep 92 V-M NK AFoxCazSSuCTe _ New5 (JJPX01.0249) ND >125, 3.5 R1
00-7093 2000 Sep 77 II-F Stool AFoxCazSSuCTe _ New 7 ST45 >125, 90 R1
00-7098 2000 Sep 93 II-F Stool AFoxCazSSuCTe _ New6b (JJPX01.0014) ND >125, 90 R1
00-7298 2000 Sep 77 IV-F Stool AFoxCazSSuCTe _ New6b (JJPX01.0014) ND >125, 90 R1
00-7325 2000 Sep 75 IV-F Stool AFoxCazSSuCTe _ New6b (JJPX01.0014) ST45 >125, 90 R1
00-7400 2000 Sep 77 IV-M Stool AFoxCazSSuCTe _ New6b (JJPX01.0014) ND >125 R1
00-7490 2000 Sep 89 II-M Stool AFoxCazSSuCTe _ New6b (JJPX01.0014) ND >125, 90 R1
00-7777 2000 Oct 77 II-F NK AFoxCazSSuCTe _ New6b (JJPX01.0014) ND >125, 90 R1
00-8066 2000 Oct 93 II-F Stool AFoxCazSSuCTe _ New6b (JJPX01.0014) ND >125, 90 R1
01-2010 2001 Apr 92 V-F Stool AFoxCazSSuCTe _ New6a (JJPX01.0176) ND >125, 60, 3.5 R2
01-2288 2001 Arp 93 IV-F Blood AFoxCazSSuCTe _ New6a (JJPX01.0176) ST45 >125, 60, 3.5 ND
01-9637 2001 Dec 95 NK-F Stool AFoxCazSSuCTe _ New6b (JJPX01.0014) ND >125, 3.5 R1
01-9867 2001 Dec 93 III-F Stool AFoxCazSSuCTe _ New6b (JJPX01.0014) ND >125, 3.5 ND
01-10075 2001 Dec 77 II-M Stool AFoxCazSSuCTe _ New6b (JJPX01.0014) ND >125, 3.5 ND
02-7891 2002 Oct 78 III-M Stool AFoxCazSSuCTe _ New8a ST45 >125, 3.5 R1
03-3125 2003 May 62 II-F Stool AFoxCazSSuCTe _ New8b ND >125, 70, 3.5 R2
03-3136 2003 May 62 III-F Stool AFoxCazSSuCTe _ New8a ND >125, 3.5 R1
03-3179 2003 May 62 III-M Stool AFoxCazSSuCTe _ New8c ND >125, 60 R1
03-3184 2003 May 62 IV-F Stool AFoxCazSSuCTe _ New8a ST45 >125, 3.5 R2
03-3222 2003 May 62 V-F Blood AFoxCazSSuCTe _ New8a ND >125, 3.5 ND
03-3224 2003 May 59 IV-M Stool AFoxCazSSuCTe _ New8a ND >125, 3.5 ND
03-3225 2003 May 59 IV-F Stool AFoxCazSSuCTe _ New8a ND >125, 3.5 R1
03-3243 2003 May 91 III-M Stool AFoxCazSSuCTe _ New8a ND >125, 3.5 ND
03-3265 2003 May 62 II-M Stool AFoxCazSSuCTe _ New8d ND >125, 100, 60, 3.5 ND
03-3349 2003 May 62 NK-F Stool AFoxCazSSuCTe _ New8d ST45 >125, 100, 60, 3.5 R2
03-3350 2003 May 62 II-M Stool AFoxCazSSuCTe _ New8c ND >125, 60, 3.5 R1
03-3465 2003 May 59 V-M Stool AFoxCazSSuCTe _ New8a ND >125, 3.5 ND
03-3519 2003 May 59 II-F Stool AFoxCazSSuCTe _ New8d ND >125, 100, 60, 3.5 R1
03-3603 2003 Jun 59 III-M Stool AFoxCazSSuCTe _ New8d ND >125, 100, 60, 3.5 R1
03-3642 2003 Jun 92 IV-NK Stool AFoxCazSSuCTe _ New8a ND >125, 3.5 ND
03-4620 2003 Jul 62 IV-M Stool AFoxCazSSuCTe _ New8a ND >125, 3.5 R1
03-5145 2003 Jul 59 III-M Stool AFoxCazSSuCTe _ New8d ST45 >125, 100, 60, 3.5 R1
03-6521 2003 Sep 59 IV-M Stool AFoxCazSSuCTe _ New6d/8e ST45 >125, 100, 3.5 R2
03-6773 2003 Sep 62 IV-F Stool AFoxCazSSuCTe _ New6d/8e ND >125, 100, 3.5 R1
03-7268 2003 Sep 62 IV-M Stool AFoxCazSSuCTe _ New6b (JJPX01.0014) ND >125, 100, 3.5 R1
03-7338 2003 Sep 62 IV-M Stool AFoxCazSSuCTe _ New6d/8e ST45 >125, 100, 3.5 R1
03-8748 2003 Nov 11 V-M Stool ACroSuTmp ND New9 ST118 ND ND
03-9969 2003 Dec 59 V-F Stool AFoxCazSSuTe _ New6c ST45 >125, 40, 5 R6
04-4556 2004 Jul 11 V-F Stool AFoxCazSSuCTe _ New9 ND >125, 3.5 R1
04-9597 2004 Dec 95 V-F Urine AFoxCazSSuCTe _ New10 ST45 >125, 3.5 R1
S. Newport reference strain

50 K Pan susceptible ND New1 ST31 ND ND
CMY-2–producing S. Typhimurium isolate

03-9243 2003 Oct 44 V-F Stool AFoxCazSKToGSuTmpCNal STM53 ND 220, 90 R7
CMY-2–producing S. Agona isolates

02-2049 2002 Apr 93 V-NK Stool AFoxCazSKSuTmpCTe 1.2 (dfrA1-orfX) Ago1 (JABX01.0055) ND 140 R8
02-2059 2002 Apr 77 V-F Stool AFoxCazSKSuTmpCTe 1.2(dfrA1-orfX) Ago1 (JABX01.0055) ND 140 R8

*PFGE, pulsed-field gel electrophoresis; MLST, multilocus sequence typing; ST, sequence type; ND, not determined; NK, not known.

†Numbers are those of Départements (French administrative subdivisions) in the Paris metropolitan area (Départements 60, 75, 77, 78, and 91–95) and northern France (Départements 59 and 62).
‡I, <1 y; II, 1–5 y; III, 6–14 y; IV, 15–64-y; V, >65 y.
§A, amoxicillin; Fox, cefoxitin; Caz, ceftazidime; S, streptomycin; Su, sulfonamides; C, chloramphenicol; Te, tetracycline; K, kanamycin; To, tobramycin; G, gentamicin; Sp, spectinomycin; Cro, ceftriaxone; Tmp, trimethoprim; Nal, nalidixic acid.
¶Profiles in parentheses were obtained from the PulseNet USA database (www.cdc.gov/pulsenet).
#Determined by the alkaline lysis method.
**Profiles are shown in Figure 2.

1Current affiliation: Institut Pasteur, St. Petersburg, Russia.

2Current affiliation: Institut Pasteur, Casablanca, Morocco.

This page posted May 23, 2008


Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435